The removal of legal hurdles significantly increases the likelihood of Garg's consent solicitation succeeding. Monitor for stockholder response and any settlement announcements. A successful removal of the five directors would likely lead to Garg's reinstatement as CEO and potential strategic changes.
Price Chart
Executive Summary
Founder Vishal Garg (13.7% stake) filed a definitive consent solicitation statement (DFAN14A) to remove five directors, escalating the proxy fight. A federal court rejected management's attempt to halt the solicitation, and the Delaware Court of Chancery confirmed that signing the GREEN consent card will not trigger the company's poison pill. This removes key legal obstacles and increases the probability of Garg succeeding in ousting the board and reinstating himself as CEO.
Key Facts
- Garg Group filed definitive consent solicitation to remove five directors: Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan, Harit Talwar.
- Federal court denied Better's application for TRO and preliminary injunction, allowing the consent solicitation to proceed.
- Delaware Court of Chancery confirmed that signing the GREEN consent card does not trigger the poison pill, per Better's own counsel.
- Garg claims majority shareholder support (>50.1% of voting power) and has already delivered signed consents.
- The board removal would trigger change-of-control provisions in equity plans and severance agreements.
Financial Impact
No financial figures disclosed in this filing; the impact is on corporate control and governance.
Risk Factors
- Historical underperformance of BETR stock and poor track record of prior activist campaigns at this company.
- Management may continue legal challenges or adopt additional defensive measures.
- Uncertainty about whether Garg can actually secure the required consents despite claiming majority support.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DFAN14A Filing (Primary) | 0000921895-26-002488 |
| Document: 0000921895-26-002488-index-headers.html | 0000921895-26-002488 |
| Document: 0000921895-26-002488-index.html | 0000921895-26-002488 |
| Document: 0000921895-26-002488.txt | 0000921895-26-002488 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 16d ago | ANALYST-UPGRADE | $11.79 $9.86 | ▼ −16.37% | ▼ −17.53% | $9.95 (−15.61%) |
Sep 14, 2026 4w ago | DEFA14A | $12.77 $13.14 | ▼ −2.90% | ▼ −0.77% | $9.95 (+22.08%) |
Sep 11, 2026 5w ago | DFAN14A | $12.77 $12.42 | ▼ −2.70% | ▼ −2.81% | $9.95 (−22.05%) |
Sep 4, 2026 6w ago | DFAN14A | $13.60 $12.77 | ▼ −6.10% | ▼ −4.98% | $9.95 (−26.84%) |
Sep 4, 2026 6w ago | DEFA14A | $13.60 $12.77 | ▼ −6.10% | ▼ −4.98% | $9.95 (−26.84%) |
Aug 31, 2026 6w ago | DEFA14A | $13.84 $13.96 | ▲ +0.87% | ▲ +1.01% | $9.95 (−28.11%) |
Aug 28, 2026 7w ago | DEFA14A | $13.84 $13.96 | ▲ +0.87% | ▲ +1.01% | $9.95 (−28.11%) |
Aug 24, 2026 7w ago | DEFA14A | $12.30 $12.23 | ▼ −0.57% | ▼ −0.03% | $9.95 (−19.11%) |
Aug 19, 2026 8w ago | PREC14A | $11.60 $14.59 | ▼ −25.78% | ▼ −24.66% | $9.95 (+14.22%) |
Aug 18, 2026 8w ago | DEFA14A | $13.03 $13.41 | ▼ −2.92% | ▼ −3.30% | $9.95 (+23.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access